Afshin Shafiee, PhD (he/him/his)

Sr. Director, Toxicology
AN2 Therapeutics

Disclosure(s): AN2 Therapeutics: Stocks/Bonds

Afshin Shafiee, PhD, Sr. Director, Toxicology, AN2 Therapeutics
Independent Consultant (Oakland, CA)
InSite Vision, Director, Preclinical Research & Development (Alameda, CA)
Bausch & Lomb, Principal Scientist (Rochester, NY)

Education
PhD, University of Aberdeen (UK)
MSc Toxicology, University of Surrey (UK)
BSc Applied Biology, Nottingham Trent University (UK)

Expertise:
• Toxicology, DMPK and Ocular Pharmacology
• Regulatory Filings
• Business Development
• Directing Projects and Leading Scientific Teams
• Managing and Monitoring Outsourced Studies
• Managing Scientists

Poster(s):

• 1716 - In Vitro Drug-Drug Interaction Evaluation of Epetraborole, a Novel Bacterial Leucyl-tRNA Synthetase Inhibitor
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET